Document is current
Any future updates will be listed below
-
Authors
Johnson, Graham http://orcid.org/0000-0001-6004-6244
Tabner, Andrew
Fakis, Apostolos
Sherman, Rachelle
Chester, Victoria
Bedford, Elizabeth
Jackson, Richard
Ratan, Hari
Mason, Suzanne
-
Funding
Funding for this research was provided by:
Research for Patient Benefit Programme (PB-PG-0817-20044)
- License Information
-
More Information
Article History
Received: 3 February 2022
Accepted: 26 March 2022
First Online: 25 April 2022
Declarations
:
: The trial has received ethical approval from West of Scotland REC 1 (19/WS/0087), in addition to the approval from the Medicines for Human Use Regulatory Authority (MHRA) (CTA 17854/0206/001-0001) and the Health Research Authority (HRA). The IRAS project ID is 252075 and EudraCT: 2018-004305-11.Written, informed consent to participate will be sought from all participants prior to any study-related activities taking place. The trial consent form is available on request.
: This section is not applicable to this publication.
: The authors declare that they have no competing interests.
